Navigation Links
Bayer Healthcare to Pay U.S. $97.5 Million to Settle Allegations of Paying Kickbacks to Diabetic Suppliers
Date:11/25/2008

WASHINGTON, Nov. 25 /PRNewswire-USNewswire/ -- Bayer HealthCare LLC (Bayer) has agreed to pay the United States$97.5 million plus interest to settle allegations that it paid kickbacks to a number of diabetic suppliers and caused those suppliers to submit false claims to Medicare, the Justice Department announced today. The settlement resolves allegations that Bayer engaged in a cash-for-patient scheme through which the company paid 11 diabetic suppliers to convert their patients to Bayer's products from supplies manufactured by its competitors.

The Tarrytown, N.Y.-based company manufactures diabetic self-testing supplies, including glucose monitors and testing strips. Bayer contracts with direct-to-patient diabetic suppliers who market and sell these products to beneficiaries and submit claims for reimbursement to Medicare.

Between 1998 and 2002, Bayer allegedly paid Liberty Medical Supply Inc., one of the largest direct-to-patient diabetic suppliers, approximately $2.5 million to convert its patients to Bayer supplies. The alleged kickbacks were based on the number of patients that Liberty successfully converted to Bayer supplies and were disguised as payments for advertising. In addition, Bayer allegedly paid kickbacks of approximately $375,000 to 10 other diabetic suppliers to convert patients to Bayer supplies.

"If medical device manufacturers want to serve Medicare beneficiaries they must follow the law," said Gregory G. Katsas, Assistant Attorney General for the Civil Division. "Paying healthcare suppliers to place a particular brand of device with Medicare beneficiaries violates the law and will not be tolerated."

The settlement resolves claims submitted to Medicare by the 11 suppliers for Bayer supplies from 1998 through 2007. Under the terms of the settlement, Bayer agreed to enter into a corporate integrity agreement with the Office of Inspector General for
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governors Plea to Help the States Population in Need
2. Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign
3. Bayer Diabetes Care Names Walk In Nicks Shoes (W.I.N.S.) Sweepstakes Grand Prize Winners
4. Bayer Marketing Two Unapproved Aspirin Products: FDA
5. Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors
6. Bayer Diabetes Care Partners with Nick Jonas to Encourage Young People to Proactively Manage Their Diabetes
7. Photos: Bayer Names New U.S. CEO
8. Bayer USA Foundation Supports Summer Science Education Programs in Pittsburgh, Raleigh, Houston and Tyler, Texas
9. Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
10. Statement From Bayer(R) Aspirin Regarding the American Medical Associations New Aspirin Policy Resolution
11. Bayer Announces Availability of Reformulated Liquid Leukine(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...ot;This is an opportunity for you to change your l...ree pills, you will experience a noticeable relief... sugar, cholesterol levels and blood pressure will...nd your mind will finally be freed from the health...tient." , Miami, FL ...
(Date:7/2/2009)...ioprocessing Technology Institute (BTI) have made ...is inhibitory molecule" (FAIM), protects both immu...ell death. , Their research is published in the... , The scientists, Jianxin Huo, Ph.D., and Sheng...y possibly be manipulated for clinical application...
(Date:7/2/2009)...re-USNewswire/ -- Pro-life forces won an important...d to uphold a state law regulating that abortion c...nistering RU-486 (also known as the "abortion pill...he drug. , , The ruling came in Rogers v. Pla...d to a 2004 law requiring that those administering...
(Date:7/2/2009)...lp reduce threat, expert says , , THURS...threat to certain species of wildlife, which need ...hers say. , "Cancer is one of the leading healt... percent of human deaths. But we now understand th... lead author Denise McAloose, chief pathologist fo...
Breaking Medicine News(10 mins):Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Cancer Endangers Some Wildlife Species 2
...ional supplement used by weightlifters and sprinte...cle strength to people with// muscular dystrophies...percent among patients taking creatine, compared t..., according to a recent review of studies. Creatin...
...o control schizophrenia symptoms, may also help tr...ccording to a new review of studies.// The review... studies of risperidone (Risperdal) involving 211 ...adults. “[We found] that risperidone may be bene...
... news in the report released by the Health Protect...t figures representing cases of infection by bugs ...stridium difficile and the ‘super bug’ MRSA. Acco...s the figures for Clostridium infections have rise...
...otball player, is in the dock. The Canadian Footba...rosecuted //for not disclosing the fact that he wa...ips with two women. According to an agreed list of...rt, Smith tested HIV positive and was informed abo...
Other Medicine News:Health News:Creatine Supplement May Help People With Muscular Dystrophies 2Health News:Antipsychotic Drug Controls Some Symptoms in Autism Disorder 2Health News:Lethal Hospital Bug Tough to Knock Down, Statistics Reveal 2
(Date:6/29/2009)... June 29 Vantia Therapeutics, an,...small molecule drugs,targeting large, underserved...,a Phase IIa clinical trial of its lead developmen...d that oral VA106483 was successful in producing a...n patients, as determined by,increased osmolality...
(Date:6/26/2009)...6 Sanofi-aventis (EURO...re of data associated with a retrospective follow-...e data clearly show that no definitive conclusions...ship between Lantus(R) (insulin glargine [rDNA] in...s the authors of the study point out. , , Clini...
(Date:6/25/2009)...wire-USNewswire/ -- As of mid-2009, The Michael J....dy funded over $1 million in high-risk, high-rewar...t through its groundbreaking Rapid Response Innov...the safety and efficacy of an FDA-approved drug fo...ation of a tenuous link between PD and certain str...
(Date:6/24/2009)... 25 , - Recruitme...e,Non-Surgical Treatment of Eye Disease With No R...uronext Brussels: THR), a biotechnology company,f...ive treatments for eye,disease, vascular disease ...,microplasmin, which is in Phase III trials for th...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3InVitria Reveals Technology to Optimize Hybridoma Production Performance 43244 1InVitria Reveals Technology to Optimize Hybridoma Production Performance 43244 2Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 1Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 2Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 3Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 4Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 5Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 6Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 7Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 8Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 9Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 10Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 11Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 12Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 13New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 1New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 2New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 3New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 4University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 1University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 2University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 3
... Potent Synergy, Activity and Patient Tolerance Su...ry Therapy, BARCELONA, Spain, April 12, 2007 /PRNe...y held biopharmaceutical company,today announced ...eron with or without ribavirin in treatment-naive ...results demonstrate that,omega interferon in combi...
... SOUTH SAN FRANCISCO, Calif., April 11, 2007 (PRI...biopharmaceutical company focused,on advancing can...ta(tm) (talotrexin) for Injection at the American ...ng April 14-18, 2007 in Los,Angeles, California. ,... with,paclitaxel in A549 non-small cell lung cance...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
Disposable Microscissors: Horizontal Curved Microscissors
Sharp tipped illuminated scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and
Disposable Microscissors: Vertical, 90
Sharp tipped scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and all purpose
Medicine Products: